Autopsy report · NCT01636466

The Everolimus-Transplant Exit Strategy Trial (E-TEST)

“Feasibility”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months before it started.
• Ran for about 11 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 1 year 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Ashtar Chami

Sponsor type

University, hospital or other

Conditions

Kidney Failure, Chronic

Interventions

Everolimus

Participants

1

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.